| Trial ID: | L2260 |
| Source ID: | NCT00655330
|
| Associated Drug: |
Valsartan
|
| Title: |
Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Nephropathy
|
| Interventions: |
DRUG: Valsartan|DRUG: Placebo|DRUG: Probucol
|
| Outcome Measures: |
Primary: urinary albumin excretion or proteinuria at week 48, 48 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Guangdong Provincial People's Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
170
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-05
|
| Completion Date: |
2017-05
|
| Results First Posted: |
|
| Last Update Posted: |
2016-08-24
|
| Locations: |
Guangdong General Hospital, Guangzhou, Guangdong, 510080, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00655330
|
